| 51 | 2ZJU |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine |
IM4 |
 |
0.55 |
SHOW |
| 52 | 4B5D |
Achbp | Capitella teleta |
I6L8L2 (I6L8L2_CAPTE) |
2-[(1R,2S)-2-[5-[[(2S)-azetidin-2-yl]methoxy]pyridin-3-yl]cyclopropyl]ethanol |
SW4 |
 |
0.55 |
SHOW |
| 53 | 4AFG |
Achbp | Capitella teleta |
I6L8L2 (I6L8L2_CAPTE) |
VARENICLINE |
QMR |
 |
0.54 |
SHOW |
| 54 | 5AFJ |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
 |
0.53 |
SHOW |
| 55 | 5KXI |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
 |
0.53 |
SHOW |
| 56 | 6USF |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens |
P43681 (ACHA4_HUMAN) |
VARENICLINE |
QMR |
|
0.52 |
SHOW |
| 57 | 5KZU |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
9-[[1-[8-methyl-8-(2-phenylethyl)-8-azoniabicyclo[3.2.1]octan-3-yl]triazol-4-yl]methyl]carbazole |
74S |
 |
0.52 |
SHOW |
| 58 | 2Y57 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1R,5S)-8-PHENETHYL-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V37 |
 |
0.52 |
SHOW |
| 59 | 6UR8 |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens |
P43681 (ACHA4_HUMAN) |
VARENICLINE |
QMR |
|
0.52 |
SHOW |
| 60 | 2XNV |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-(2-(4-PHENYLPIPERIDIN-1-YL)ETHYL)-1H-INDOLE |
VU3 |
 |
0.51 |
SHOW |
| 61 | 2XYS |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
 |
0.51 |
SHOW |
| 62 | 6PV8 |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens |
P32297 (ACHA3_HUMAN) |
(3-endo)-N-(2-bromophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine |
P1M |
 |
0.5 |
SHOW |
| 63 | 5OBH |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(5S)-6,6-dimethyl-5-[(6R)-8-oxo-6,8-dihydrofuro[3,4-e][1,3]benzodioxol-6-yl]-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-6-ium |
J94 |
 |
0.5 |
SHOW |
| 64 | 6PV7 |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens |
P32297 (ACHA3_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.5 |
SHOW |
| 65 | 6CNJ |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.49 |
SHOW |
| 66 | 2Y56 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1S,5R)-8-[(2R)-2-HYDROXY-2-PHENYL-ETHYL]-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V11 |
 |
0.49 |
SHOW |
| 67 | 5OA0 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.48 |
SHOW |
| 68 | 5LXB |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
palonosetron |
7A9 |
 |
0.48 |
SHOW |
| 69 | 2WNC |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-INDOLE-3-CARBOXYLATE |
TKT |
 |
0.48 |
SHOW |
| 70 | 6Y1Z |
5-hydroxytryptamine receptor 3A | Mus musculus |
P23979 (5HT3A_MOUSE) |
(3~{a}~{S})-2-[(3~{S})-1-azabicyclo[2.2.2]octan-3-yl]-3~{a},4,5,6-tetrahydro-3~{H}-benzo[de]isoquinolin-1-one |
O7B |
 |
0.46 |
SHOW |
| 71 | 2YME |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide |
CWB |
 |
0.45 |
SHOW |
| 72 | 5AFK |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.41 |
SHOW |
| 73 | 5OAL |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.41 |
SHOW |
| 74 | 5OAJ |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-INDOLE-3-CARBOXYLATE |
TKT |
|
0.41 |
SHOW |